Kevin P Killeen Selected Research

Peru 15

8/2005	Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.
4/2002	Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin P Killeen Research Topics

Disease

4	Typhoid Fever (Typhoid) 01/2022 - 05/2010
3	Cholera 12/2007 - 04/2002
1	Pneumococcal Infections 12/2021
1	Pain (Aches) 01/2020
1	Plague (Bubonic Plague) 03/2012
1	Infections 02/2005
1	Neoplasms (Cancer) 02/2003
1	Communicable Diseases (Infectious Diseases) 02/2003
1	Diarrhea 04/2002

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2022 - 04/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	AntigensIBA 12/2021 - 03/2012
2	Peru 15IBA 08/2005 - 04/2002
1	delta inulinIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Conjugate VaccinesIBA 01/2020
1	typhoid Vi polysaccharide vaccine (Typhim Vi)FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 03/2012
1	AntibodiesIBA 03/2012
1	Cholera Vaccines FDA Link 04/2002

Therapy/Procedure

1	Therapeutics 02/2003